Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solid Tumor × Vincristine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 110 Lymphoma 97 Lymphoma, Large B-Cell, Diffuse 88 Leukemia 52 Burkitt Lymphoma 45 Lymphoma, Non-Hodgkin 42 Lymphoma, Follicular 34 Lymphoma, Mantle-Cell 31 Hodgkin Disease 24 Lymphoma, Large-Cell, Immunoblastic 14 Retinoblastoma 13 Lymphoma, Large-Cell, Anaplastic 13 Central Nervous System Neoplasms 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma, T-Cell, Peripheral 12 Lymphoma, B-Cell 12 Sarcoma 11 Recurrence 11 Neuroblastoma 11 Lymphoma, B-Cell, Marginal Zone 11 Immunoblastic Lymphadenopathy 10 Sarcoma, Ewing 9 Rhabdomyosarcoma 9 Medulloblastoma 9 Neoplasms 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Dendritic Cell Sarcoma, Interdigitating 8 Multiple Myeloma 6 Leukemia, Biphenotypic, Acute 6 Enteropathy-Associated T-Cell Lymphoma 6

Interventions

Fluorodeoxyglucose F18 7 Irinotecan 4 Fluorouracil 4 Bevacizumab 4 pembrolizumab 3 olaparib 3 Radiosurgery 3 Cyclophosphamide 3 Cisplatin 3 Capecitabine 3 vistusertib 2 toripalimab 2 tislelizumab 2 spartalizumab 2 fludarabine 2 atezolizumab 2 apatinib 2 Temozolomide 2 Radiotherapy 2 Proton Therapy 2 Paclitaxel 2 Leucovorin 2 Letrozole 2 Hydroxychloroquine 2 Everolimus 2 Drug Therapy 2 Docetaxel 2 tumor-cells apoptosis factor, human 1 trifluridine tipiracil drug combination 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00786669 2021-02-10

VITAC

Children's Hospital Medical Center, Cincinnati

Phase 1 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡